Bellerophon Therapeutics
BLPH
#10452
Rank
HK$1.15 M
Marketcap
HK$0.09420
Share price
-36.84%
Change (1 day)
-79.90%
Change (1 year)

Bellerophon Therapeutics (BLPH) - Total liabilities

Total liabilities on the balance sheet as of September 2023 : HK$9.85 Million

According to Bellerophon Therapeutics 's latest financial reports the company's total liabilities are HK$9.85 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bellerophon Therapeutics - Total liabilities on balance sheet (from 2013 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31HK$42.19 M2.97%
2021-12-31HK$40.98 M-55.91%
2020-12-31HK$92.94 M25.4%
2019-12-31HK$74.11 M-34.74%
2018-12-31HK$0.11 B-63.11%
2017-12-31HK$0.30 B239.03%
2016-12-31HK$90.8 M45.12%
2015-12-31HK$62.57 M-22.83%
2014-12-31HK$81.08 M-46.02%
2013-12-31HK$0.15 B33.98%
2012-12-31HK$0.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Baxter
BAX
HK$111.85 B 1,134,454.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
HK$0.45 B 4,515.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$254.20 B 2,578,243.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Lantheus Holdings
LNTH
HK$6.99 B 70,841.88%๐Ÿ‡บ๐Ÿ‡ธ USA